Sherri Haas, DO
Pain Medicine · Edina, MNNPI 1366686370
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Abbott accounts for 62.6% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $32,168 and has fallen 98.2% since, to $591 in 2025. Among pain medicine clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 220 payments — averaging $230.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$32K
- Boston Scientific$15K
- Si-bone, Inc.$2K
- Medtronic$1K
- Nevro Corp.$272
- Relievant Medsystems, Inc.$97
- plus $125 from 6 others
Across 21 payments — averaging $2465.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$51K
- Medtronic$954
What the payments were for
- Consulting fees$4,3589%
- Speaking & faculty fees$29,48858%
- Travel & lodging$10,09720%
- Food & beverage$6,70513%
- Education$400%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 132 | $31,718 |
| Boston Scientific | 44 | $15,468 |
| Si-bone, Inc. | 8 | $1,617 |
| Medtronic(2 entities) | 23 | $1,389 |
| Nevro Corp. | 5 | $272 |
| Relievant Medsystems, Inc. | 2 | $97 |
| Biotronik NRO, Inc. | 1 | $43 |
| SPR Therapeutics, Inc | 1 | $21 |
| Vertos Medical, Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
| Stimwave Technologies Incorporated | 1 | $14 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$19,659
- WaveWriter Alpha Prime 16$6,716
- IonicRF Generator$4,000
- GENERAL - THERAPIES$3,741
- WAVEWRITER ALPHA$3,187
- Neuromodulation Dspsbls and Accs$2,200
- Proclaim DRG IPG$1,482
- IFUSE IMPLANT SYSTEM$1,346
- PRODIGY$1,069
- Superion Indirect Decompression System$739
- Axium$710
- Proclaim IPG$439
- VECTRIS$358
- Proclaim Family of SCS IPGs$296
- SPECTRA WAVEWRITER$227
- INTELLIS$154
- SYNCHROMEDII$152
- RESTORE$146
- OCTRODE$145
- ETERNA$144
How this compares
$50,687 in reported general payments places this provider in the 90th percentile of 88 pain medicine providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LyricaPregabalin | 12 | $10,708 |
| Buprenorphine | 13 | $3,479 |
| Fentanyl | 26 | $2,701 |
| Oxycodone Hcl | 107 | $2,248 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 74 | $1,928 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 69 | $1,789 |
| Pregabalin | 77 | $1,450 |
| Gabapentin | 65 | $1,020 |
| Hydromorphone Hcl | 39 | $812 |
| Tizanidine Hcl | 21 | $719 |
| Morphine Sulfate ErMorphine Sulfate | 28 | $654 |
| Tramadol Hcl | 53 | $399 |
| Duloxetine Hcl | 12 | $259 |
| Methocarbamol | 24 | $217 |
| Cyclobenzaprine Hcl | 47 | $186 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerLyrica | $14 | $10,70812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 88 pain medicine providers in Minnesota.
Other pain medicine in Edina
- Richard StaynerEdina$105K
- David SchultzEdina$99K
- Matthew ThorsonEdina$59K
- Louis SaegerEdina$28K
- Andrew WillEdina$22K
- Aaron BloomEdina$6K
- Rachel WilsonEdina$3K
- Daniel SippleEdina$2K
- Jonathan HagedornRochester$83K
- Michael McEntireRochester$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.